Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian population
- PMID: 25685788
- PMCID: PMC4320885
- DOI: 10.1155/2015/427519
Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian population
Abstract
Among the factors postulated to play a role in MS susceptibility, the role of vitamin D is outstanding. Since the function of vitamin D receptor (VDR) represents the effect of vitamin D on the body and genetic variations in VDR gene may affect its function, we aim to highlight the association of two VDR gene polymorphisms with MS susceptibility. In current study, we recruited 113 MS patients and 122 healthy controls. TaqI (rs731236) and ApaI (rs7975232) genetic variations in these two groups were evaluated using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. All genotype and allele frequencies in both variations showed association with the disease status. However, to find the definite connection between genetic variations in VDR gene and MS disease in a population of South East of Iran, more researches on gene structure and its function with regard to patients' conditions are required.
Similar articles
-
ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks.Neurol Res. 2016 Aug;38(8):678-84. doi: 10.1080/01616412.2016.1200287. Epub 2016 Jun 23. Neurol Res. 2016. PMID: 27338176
-
Association between vitamin D receptor ApaI and TaqI gene polymorphisms and gestational diabetes mellitus in an Iranian pregnant women population.Gene. 2016 Apr 25;581(1):43-7. doi: 10.1016/j.gene.2016.01.026. Epub 2016 Jan 16. Gene. 2016. PMID: 26784653
-
Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.J Neurol Sci. 2016 Aug 15;367:148-51. doi: 10.1016/j.jns.2016.05.053. Epub 2016 Jun 1. J Neurol Sci. 2016. PMID: 27423580
-
Vitamin D and its immunoregulatory role in multiple sclerosis.Drugs Today (Barc). 2010 Apr;46(4):279-90. doi: 10.1358/dot.2010.46.4.1476498. Drugs Today (Barc). 2010. PMID: 20502725 Review.
-
Vitamin D and Genetic Susceptibility to Multiple Sclerosis.Biochem Genet. 2021 Feb;59(1):1-30. doi: 10.1007/s10528-020-10010-1. Epub 2020 Nov 7. Biochem Genet. 2021. PMID: 33159645 Review.
Cited by
-
Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis.BMC Neurol. 2019 Dec 26;19(1):339. doi: 10.1186/s12883-019-1577-y. BMC Neurol. 2019. PMID: 31878897 Free PMC article.
-
Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review.Front Immunol. 2023 Jul 14;14:950465. doi: 10.3389/fimmu.2023.950465. eCollection 2023. Front Immunol. 2023. PMID: 37520529 Free PMC article. Review.
-
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.Med Microbiol Immunol. 2016 Apr;205(2):143-54. doi: 10.1007/s00430-015-0437-7. Epub 2015 Sep 13. Med Microbiol Immunol. 2016. PMID: 26365612
-
Vitamin D Receptor Polymorphisms Among the Turkish Population are Associated with Multiple Sclerosis.Balkan J Med Genet. 2023 Mar 1;25(1):41-50. doi: 10.2478/bjmg-2022-0003. eCollection 2022 Jun. Balkan J Med Genet. 2023. PMID: 36880035 Free PMC article.
-
Vitamin D Receptor Polymorphism and Myasthenia Gravis in Chinese Han Population.Front Neurol. 2021 Feb 9;12:604052. doi: 10.3389/fneur.2021.604052. eCollection 2021. Front Neurol. 2021. PMID: 33633666 Free PMC article.
References
-
- Patsopoulos N. A., Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology. 2011;70(6):897–912. doi: 10.1002/ana.22609. - DOI - PMC - PubMed
-
- Malloy P. J., Eccleshall T. R., Gross C., van Maldergem L., Bouillon R., Feldman D. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. Journal of Clinical Investigation. 1997;99(2):297–304. doi: 10.1172/jci119158. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical